At the 2025 Scientific and Technical Conference organized by Saigon Medical Group under the theme “Modern Technology, JCI Quality,” the field of Ophthalmology marked a notable professional milestone. MSc, MD Nguyen Phu Tung – Hospital Director and Medical Director of Sai Gon Ngo Gia Tu Eye Hospital – excellently achieved the A Prize for his scientific research presentation in the Ophthalmology session.
Study Evaluating One-Year Outcomes After Phakic ICL and IPCL Surgery

MSc, MD Nguyen Phu Tung at the 2025 Scientific and Technical Conference
Within the framework of the conference held on September 20, 2025, MSc, MD Nguyen Phu Tung presented an in-depth study evaluating one-year outcomes following Phakic ICL and IPCL surgery in patients with myopia and astigmatism. The study was conducted based on real-world clinical data from Sai Gon Ngo Gia Tu Eye Hospital, clearly reflecting its applicability and practical value in treatment.
The report focused on analyzing visual outcomes, refractive accuracy, and the safety profile of the two Phakic IOL procedures. The results demonstrated that both Phakic ICL and IPCL deliver high, stable effectiveness with comparable accuracy in the treatment of myopic astigmatism, particularly in patients who are not suitable candidates for laser refractive surgery.
The Professional Journey of a Highly Experienced Ophthalmologist

MSc, MD Nguyen Phu Tung presenting his scientific research at the 2025 Scientific and Technical Conference
MSc, MD Nguyen Phu Tung is one of the ophthalmologists with extensive experience in Vietnam. With more than 26 years in the field, he has personally performed over 560 Phakic refractive surgeries, including many complex cases with myopia up to 20 diopters and astigmatism up to +5.5 diopters.
In addition to his clinical experience, Dr. Nguyen Phu Tung has been honored by STAAR Surgical – the world’s leading manufacturer of EVO ICL intraocular lenses – with the title “Phakic Refractive Surgery Expert.” He is also among the few Vietnamese doctors to hold international certification in Phakic IOL techniques, affirming his professional competence to global standards.
Scientific Value and Future Development Orientation

MSc, MD Nguyen Phu Tung receiving the A Prize for scientific research at the 2025 Scientific and Technical Conference
The study was highly regarded not only for its positive outcomes but also for its data-driven approach based on real clinical practice. The report showed that Phakic IOLs enable treatment across a wider range of refractive errors while preserving the eye’s natural accommodative function. This is a significant advantage for younger patients, those with high myopic astigmatism, or individuals with thin corneas.
From these initial results, the study opens new directions for advancing and standardizing solutions for myopic astigmatism treatment using Phakic ICL and IPCL in Vietnam. In the coming period, MSc, MD Nguyen Phu Tung and his professional team plan to expand the research with a larger sample size, longer follow-up duration, and the inclusion of presbyopic patient groups to further optimize treatment outcomes.
The A Prize awarded at the 2025 Scientific and Technical Conference is not only a well-deserved recognition of the rigorous research efforts of MSc, MD Nguyen Phu Tung, but also reaffirms the pioneering role of Sai Gon Ngo Gia Tu Eye Hospital in applying modern ophthalmic technologies toward international-standard treatment quality.






